Research Library

The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.

Will OPEC+ begin to reverse large production cuts at its June 1 meeting? In large part, it will depend on whose oil market outlook is closest to the mark, writes Mark Finley, fellow in energy and global oil. He examines several forecasts and outlines the issues in a new commentary.

Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.

As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.

U.S. oil refiners have had a great run this century. But market events in 2020 signal changes to come that will challenge the industry’s global competitiveness, writes fellow in energy and global oil Mark Finley.

Read the Baker Institute Blog for the latest updates on the spread of Covid-19 and the best defenses against it.

Fellow Vivian Ho discusses the sources she's following that shape her thoughts on how long the pandemic will last and what policy actions seem most promising. Baker Institute Blog: https://bit.ly/3aRTDrF

International and domestic oil and gas markets and prices are under heavy pressure from COVID-19 impacts and the Russian-Saudi Arabia oil market battle. With, all eyes are on U.S. domestic producers, especially those occupying the shale patch, Michelle Michot Foss, fellow in energy and minerals, provides some important considerations for the U.S. oil and gas industry. Forbes Blog: http://bit.ly/2WqVEqt